Quantitative Prediction of CYP3A4‐ and CYP3A5‐Mediated Drug Interactions by Guo, Yingying, Lucksiri, Aroonrut, Dickinson, Gemma L., Vuppalanchi, Raj K., Hilligoss, Janna K., Hall, Stephen D.

Get full text

GDF8 Contributes to Liver Fibrogenesis and Concomitant Skeletal Muscle Wasting by Culver, Alexander, Hamang, Matthew, Wang, Yan, Jiang, Huaizhou, Yanum, Jennifer, White, Emily, Gawrieh, Samer, Vuppalanchi, Raj K, Chalasani, Naga P, Dai, Guoli, Yaden, Benjamin C

Get full text

NASH resolution is associated with improvements in HDL and triglyceride levels but not improvement in LDL or non‐HDL‐C levels by Corey, K. E., Vuppalanchi, R., Wilson, L. A., Cummings, O. W., Chalasani, N.

Get full text

Quantitative assessment of disease severity of primary sclerosing cholangitis with T1 mapping and extracellular volume imaging by Evrimler, Sehnaz, Swensson, Jordan K., Are, Vijay S., Tirkes, Temel, Vuppalanchi, Raj, Akisik, Fatih

Get full text

Optimizing therapy in primary biliary cholangitis: Alkaline phosphatase at six months identifies one‐year non‐responders and predicts survival by Murillo Perez, C. Fiorella, Ioannou, Stephanie, Hassanally, Iman, Trivedi, Palak J., Corpechot, Christophe, Meer, Adriaan J., Lammers, Willem J., Battezzati, Pier Maria, Lindor, Keith D., Nevens, Frederik, Kowdley, Kris V., Bruns, Tony, Cazzagon, Nora, Floreani, Annarosa, Mason, Andrew L., Gulamhusein, Aliya, Ponsioen, Cyriel Y., Carbone, Marco, Lleo, Ana, Mayo, Marlyn J., Dalekos, George N., Gatselis, Nikolaos K., Thorburn, Douglas, Verhelst, Xavier, Parés, Albert, Londoño, Maria‐Carlota, Janssen, Harry L. A., Invernizzi, Pietro, Vuppalanchi, Raj, Hirschfield, Gideon M., Hansen, Bettina E., Levy, Cynthia

Get full text

The INGENIOUS trial: Impact of pharmacogenetic testing on adverse events in a pragmatic clinical trial by Eadon, Michael T., Rosenman, Marc B., Zhang, Pengyue, Fulton, Cathy R., Callaghan, John T., Holmes, Ann M., Levy, Kenneth D., Gupta, Samir K., Haas, David M., Vuppalanchi, Raj, Benson, Eric A., Kreutz, Rolf P., Tillman, Emma M., Shugg, Tyler, Pierson, Rebecca C., Gufford, Brandon T., Pratt, Victoria M., Zang, Yong, Desta, Zeruesenay, Dexter, Paul R., Skaar, Todd C.

Get full text

Rate of onset of inhibition of gut-wall and hepatic CYP3A by clarithromycin by Quinney, Sara K., Malireddy, Srikar R., Vuppalanchi, Raj, Hamman, Mitchell A., Chalasani, Naga, Gorski, J. Christopher, Hall, Stephen D.

Get full text